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The first structure of the catalytic domain of RpfC (Rv1884), one of the
resuscitation-promoting factors (RPFs) from Mycobacterium tuberculosis, is
reported. The structure was solved using molecular replacement once the space
group had been correctly identified as twinned P21 rather than the apparent
C2221 by searching for anomalous scattering sites in P1. The structure displays a
very high degree of structural conservation with the previously published
structures of the catalytic domains of RpfB (Rv1009) and RpfE (Rv2450). This
structural conservation highlights the importance of the versatile domain
composition of the RPF family.
1. Introduction
Resuscitation-promoting factors (RPFs) have attracted much interest
since their discovery in the late 1990s. These proteins resuscitate
bacteria that have entered a dormant state, allowing them to prolif-
erate normally. Despite some key advances since the first protein
identification and characterization, their precise mechanism of action
remains elusive. The protein was first isolated in Micrococcus luteus,
where a heat-labile, non-dialysable and trypsin-sensitive factor
present in culture supernatants was able to resuscitate non-growing
cells (Mukamolova et al., 1998). The factor was identified as a protein
and named resuscitation-promoting factor. In this same seminal
study, corresponding genes in other GC-rich Gram-positive bacteria,
most notably in Mycobacterium tuberculosis, were also identified. The
resuscitating function was later confirmed in M. tuberculosis
(Mukamolova et al., 2002). This is an important finding, as one third
of the human population is latently infected with M. tuberculosis in a
dormant form. This represents a large population reservoir for
reactivation of tuberculosis and also a potential novel therapeutic
avenue for treating tuberculosis.
Sequence analysis coupled with homology modelling led to the
hypothesis that the conserved RPF catalytic domain could be a
transglycosidase belonging to the family of c-type lysozymes (Cohen-
Gonsaud, Keep et al., 2004). The prediction was confirmed by the first
solution structure of the RpfB catalytic domain from M. tuberculosis,
which showed that the domain is a short version of the c-type lyso-
zyme lacking the first helix (Cohen-Gonsaud et al., 2005). Later,
various experiments unambiguously demonstrated that the RPF
domain is a peptidoglycan hydrolase (Mukamolova et al., 2006;
Telkov et al., 2006).
Five RPF paralogues are present in M. tuberculosis (rpfA–E). They
contain a conserved catalytic domain, but the domain composition
shows variability also found in other species (Ravagnani et al., 2005).
The mycobacterial RPF proteins share a common 70-amino-acid RPF
domain and the presence of N-terminal signal sequences suggesting
that the proteins are translocated to an extracellular location. RpfC
(176 amino acids), RpfD (154 amino acids) and RpfE (172 amino
acids) consist almost solely of the RPF domain and signal sequence
and are supposed to have a paracrine function. RpfB (362 amino
acids) possesses a G5 domain that may be involved in peptidoglycan
binding (Ruggiero et al., 2009) and a prokaryotic membrane lipo-
protein lipid-attachment site that may confer it with a juxtacrine
function, while RpfA (407 amino acids) possesses a low composi-
tional complexity domain that may confer an autocrine function
(Mukamolova et al., 1998).
Initial studies showed that deletion of individual rpf genes had no
significant phenotypic consequences (Downing et al., 2004; Tufariello
et al., 2004). This suggests that the mycobacterial RPF proteins are
functionally redundant. The deletion of the entire mycobacterial rpf
gene family is also dispensable for growth (Kana et al., 2008).
However, phenotypic alterations appear with the deletion of three or
more rpf genes and reveal a functional hierarchy of the mycobacterial
Rpf proteins that has been reviewed elsewhere (Kana & Mizrahi,
2010).
The question arises as to the functional specificity of the various
RPF paralogues. Is specificity based on small changes within the RPF
catalytic domain structure itself or on the domain organization? The
solution structure (Cohen-Gonsaud et al., 2005) and various X-ray
structures of RpfB (Ruggiero et al., 2009, 2013; Squeglia et al., 2013)
and, very recently, the structure of RpfE have been published
(Mavrici et al., 2014). In this paper, we describe the X-ray structure of
the RpfC catalytic domain. Despite the presence of multiple copies in
the asymmetric unit, twinning and strong noncrystallographic trans-
lation, we succeeded in solving the structure using molecular repla-
cement. The structure highlights the high degree of structural
conservation within the RPF domains, which could explain why the
mycobacterial paralogues are functionally redundant.
2. Methods
2.1. Protein preparation and crystallogenesis
The sequence coding for the catalytic domain of RpfC (residues
Gly68–Lys159 of UniProt RPFC_MYCTU) was cloned into the NdeI
and NheI sites of the pET15-TEV plasmid to generate a recombinant
protein containing a six-histidine tag at the N-terminus cleavable by
Tobacco Etch Virus (TEV) protease (Cohen-Gonsaud, Barthe et al.,
2004). The N-terminus after cleavage corresponds to the first amino
acid of the mature RpfC after predicted cleavage of the signal
peptide. The experimentally determined start codon is residue 34 of
the UniProt entry (RPFC_MYCTU; Raman et al., 2004) and the first
34 residues (34–67 of the UniProt entry) are the signal peptide.
Therefore, we number the protein structure from residue Gly1, which
is Gly68 in the UniProt entry. The last 17 residues of the protein were
predicted to be disordered from the RpfB structure and were
excluded from this construct.
Protein expression was carried out in Escherichia coli Rosetta2
(DE3) strain grown in ZYM5052 auto-induction medium at 25C for
36 h (Studier, 2005). Cells were harvested and lysed by sonication in
100 mM Tris pH 7.5, 2 mM -mercaptoethanol (BME) (buffer A).
The lysate was cleared by centrifugation at 48 000g for 1 h at 4C. The
supernatant was loaded onto a nickel–NTA column (GE Healthcare)
equilibrated with buffer A and was eluted with buffer A supple-
mented with 300 mM imidazole (buffer B). The eluted protein frac-
tion was dialysed (3 kDa cutoff) against 20 mM Tris pH 7.5, 2 mM
BME (buffer C) overnight at 4C in the presence of TEV protease.
The cleaved protein was further purified by gel filtration on a HiLoad
Superdex 75 column (GE Healthcare, Amersham, England) equili-
brated in buffer C before being concentrated for crystallization trials.
Crystals grew readily in 22 of the 96 conditions of The Classics Suite
(Qiagen, Hilden, Germany), but all belonged to the same space
group, with the condition 0.1 M sodium citrate pH 5, 20%(w/v) PEG
6000 giving the best crystals. Some optimization of this condition was
carried out and a slight improvement was achieved using 0.1 M
sodium citrate pH 5, 22%(w/v) PEG 6000. The crystals were cryo-
protected in the crystallization condition with 20% ethylene glycol.
2.2. Data collection, processing and phasing
Default processing of data sets using either XDS (Kabsch, 2010) or
iMosflm (Powell et al., 2013) always gave space group C2221. Data
sets were reprocessed in P21 (Table 1) with care taken to use an Rfree
selection that meant that all pseudoequivalent reflections were in the
refined or the free data set. A thin-shell Rfree file was obtained using
SFTOOLS from CCP4 (Winn et al., 2011) from an RpfC data set
indexed in C2221 with unit-cell parameters a = 65.12, b = 142.88, c =
88.93 A˚,  =  =  = 90. The initial file was expanded to the lowest
symmetry space group P1. From there, the file was modified to match
the unit-cell parameters to the integrated P21 data. The first re-
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Table 1
Data collection and processing.
Values in parentheses are for the outer shell.
Diffraction source ESRF beamline ID23-1
Wavelength (A˚) 1.0723
Temperature (C) 173
Detector ADSC Quantum 315r CCD
Crystal-to-detector distance (mm) 216.5
Rotation range per image () 0.35
Total rotation range () 210
Space group P21
a, b, c (A˚) 66.23, 89.93, 78.09
, ,  () 90, 115.08, 90
Mosaicity () 0.259
Resolution range (A˚) 44.97–1.90 (1.94–1.90)
Total No. of reflections 266668 (17421)
No. of unique reflections 64809 (4200)
Completeness (%) 99.6 (100)
Multiplicity 4.1 (4.1)
hI/(I)i 8.3 (2.6)
Rr.i.m.† 0.087 (0.439)
Overall B factor from Wilson plot (A˚2) 18.1
† Estimated Rr.i.m. = Rmerge[N/(N  1)]1/2, where N is the data multiplicity.
Table 2
Structure solution and refinement.
Values in parentheses are for the outer shell.
Resolution range (A˚) 38.42–1.90 (1.949–1.900)
Completeness (%) 99.6
 Cutoff 0
Twin fractions (h; k; l)/(h;k; h þ l) 0.537/0.463
No. of reflections, working set 61793 (4462)
No. of reflections, test set 3271 (271)
Final Rcryst 0.205 (0.216)
Final Rfree 0.236 (0.261)
ESU based on free R 0.027
No. of non-H atoms
Protein 4762
Ligand 0
Solvent (including EDO) 240
Total 5002
R.m.s. deviations
Bonds (A˚) 0.022
Angles () 1.823
Average B factors (A˚2)
Protein 31.7
Ligand 0
Water 27.3
Ramachandran plot
Most favoured (%) 98.2
Allowed (%) 1.8
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indexing was carried out to set the angle to  = 114 using the
transformation matrix (100, 001, 110) with unit-cell parameters a =
65.12, b = 88.93, c = 157.02 A˚. Finally, the software REINDEX from
CCP4 was used with settings h = h, k = k, l = l/2 to give the correct
unit-cell lengths a = 65.12, b = 88.93, c = 78.51 A˚,  =  = 90,  =
114.50. The free set was then reduced to the P21 asymmetric unit and
used as the source of free reflection flags for all other data sets.
Initial phasing was carried out by MrBUMP (Keegan & Winn,
2008) using the crystal structure of the catalytic domain of RpfB
(PDB entry 3e05; Ruggiero et al., 2009). A solution with four copies in
the asymmetric unit was found in C2221 but would not refine below
an Rfree of 0.500 using MOLREP (Vagin & Teplyakov, 2010).
However, two copies of this model were found in the P21 unit cell and
refined with the use of twinning to a final Rfree of 0.236 using
REFMAC5 (Murshudov et al., 2011; see Table 2). There is a
noncrystallographic translation of (0.554, 0.0, 0.109) in fractional
coordinates of 50% of the origin peak. With the improvements in
molecular replacement including noncrystallographic translation
since this work was originally carried out, current versions of Phaser
(McCoy et al., 2007) and MOLREP can solve this structure more
routinely from a single RpfB chain.
3. Results and discussion
3.1. Structure-solution problems
Many data sets were collected from crystals of RpfC or the point
mutations RpfC_E13A or RpfC_E13M with and without potential
substrates and including selenomethionine-substituted RpfC_E13M
at the ESRF, SLS, SOLEIL and Diamond synchrotrons. The auto-
matic space-group assignment for all data sets gave the space group
as C2221, with unit-cell parameters of around a = 66, b= 141, c= 90 A˚,
 =  =  = 90. The resolutions of the data sets ranged from 3.0 to
1.9 A˚. This would predict four copies of the RpfC chain in the
asymmetric unit. We failed to obtain a molecular-replacement solu-
tion using our NMR structure (PDB entry 1xsf; Cohen-Gonsaud et
al., 2005). Slightly better solutions were found using the crystal
structure of the RpfB catalytic domain, with R and Rfree of around
0.45 and 0.50, respectively, but these would not refine further.
Attempts at Se or S SAD also did not give solutions. However,
anomalous site searching using charge flipping (Dumas & van der
Lee, 2008), which works in P1, indicated that the data were probably
in space group P21, as eight sites could be found using the SeMet
RpfC_E13M data in this space group. This data set did not yield a
useable map, probably owing to the data set being twinned (0.41 from
a Britton plot) and the presence of only weak anomalous signal that
only extended to around 3.8 A˚ as assessed by phenix.xtriage (Zwart et
al., 2005) and CTRUNCATE from CCP4. However, molecular
replacement with the C2221 solution from the crystal structure of
RpfB (Ruggiero et al., 2009) in space group P21 (unit-cell parameters
a = 65, b = 88, c = 78 A˚,  =  = 90,  = 114.50) to give eight copies in
the asymmetric unit and refining with twin operators h; k; l and
h;k; h þ l allowed refinement to acceptable R and Rfree values on
carefully selecting the free set (see Table 2). Twinning was not
apparent from the L-test (Yeates, 1988) or the moments of E, but was
estimated for the final data set as 0.41 from the H-test (Padilla &
Figure 1
Structure of RpfC compared with RpfB and RpfE. (a) RpfC asymmetric unit and cell edges looking at the ac plane. The noncrystallographic translation of (0.554, 0.0, 0.109)
can be seen. (b) Superposition of RpfB [green; PDB entry 4kpm chain A with tri-N-acetylglucosamine (NAG)3 and benzamidine], RpfC (light blue; PDB entry 4ow1 chain A
with ethylene glycol) and RpfE (tan; PDB entry 4cge chain A) with the small insertion at the bottom left of RpfB. (c) Comparison of RpfB [PDB entry 4kpm; chain A, ice
blue; chain B, gold; (NAG)3 and benzamidine in green ball-and-stick representation] with RpfC (PDB entry 4ow1; chain A, ice blue; chain T, cyan; ethylene glycol, light blue)
and lysozyme [PDB entry 1lzs; chain A, red; (NAG)4 and (NAG)2 shown with fat red bonds]. This shows the conservation of a crystallographic interface between RpfB and
RpfC and the overlap of the ethylene glycol and benzamidine sites. All images were produced with CCP4mg (McNicholas et al., 2011).
Yeates, 2003) and 0.45 in a Britton plot (Fisher & Sweet, 1980) as
tested by CTRUNCATE. Other data sets gave similar twinning. The
final refined twinning fraction in REFMAC5 for the deposited
structure was 0.463 for h;k; h þ l. Despite soaking and co-crys-
tallizing with a range of substrates and substrate fragments, for
example N-acetylglucosamine (NAG), polymers of up to five repeats
of N-acetylglucosamine and NAG-N-acetylmuramic acid, and
peptidoglycan fragments that are generated by a number of enzymes,
we never obtained clear density for substrates in the active site. We
have therefore deposited the structure of the wild-type RpfC catalytic
domain (PDB entry 4ow1).
3.2. Structure analysis
The asymmetric unit consists of eight copies of the RpfC chain. A
set of four copies is generated by two twofold axes perpendicular to
the crystallographic twofold; a single translation of (0.554, 0.0, 0.109)
then generates the second set of four copies (Fig. 1a). Coupled with
twinning the two folds give rise to the pseudo-C2221 symmetry.
Chains A, E and S have the most residues modelled into electron
density (Gly1–Lys86) with an extra helix beyond the end of the
conserved domain (Gly78). Chain B has the least modelled residues
(Pro4–Gly78); the other chains are between these limits. We have
modelled an ethylene glycol (the cryoprotectant) where a benzami-
dine molecule is present in the RpfB structures with PDB codes 4kpm
(Squeglia et al., 2013) and 4emn (Ruggiero et al., 2013). As for the
benzamidine in 4kpm, this is only seen in one of the similar interfaces.
Benzamidine and ethylene glycol are not all that similar, but this
observation indicates that this region in RPFs prefers binding small
organic molecules to water. This region is part of the predicted
binding site of a hexasaccharide based on superposition of the lyso-
zyme-cleaved hexasaccharide complex with PDB code 1lzs (Song et
al., 1994). The crystal packing of the two adjacent chains close to the
benzamidine/ethylene glycol site is almost perfectly conserved in our
RpfC structure and in the RpfB structures, despite there being no
evidence of this contact being physiological. The two pairs of chain
superimpose with an r.m.s.d. of 1.1 A˚ over 149 residues using SSM
(Krissinel & Henrick, 2004), which is not much larger than that for
the single chains (see below). The RPF domains are sufficiently close
to clash with the superposed disaccharide in this region. The trisac-
charide in 4kpm coincides with the other part of the cleaved
saccharide in 1lzs (Fig. 1b).
As expected, the structural conservation between the new RpfC
catalytic domain structure that we have determined in this study and
the extensively studied RpfB domain is high. The calculated C
r.m.s.d. between the two structures (our structure versus PDB entry
4kl7; Squeglia et al., 2013) is only 0.90 A˚ for 76 residues aligned by
SSM with 52% sequence identity over the domain (Figs. 2a and 2b).
Compared with the recent RpfE structure (PDB entry 4cge; Mavrici
et al., 2014), the calculated C r.m.s.d. is even lower at 0.82 A˚ for 77
residues with 62% sequence identity (Figs. 1c and 2a). Most of the
backbone geometry is conserved, including the connecting loops
between the helices. This is in accordance with the first NMR struc-
ture that we determined, where the 30 calculated structures shared a
low r.m.s.d. of 0.57 A˚, low thermal motion as shown by NOE (Nuclear
Overhauser Effect) ratios (Cohen-Gonsaud, Barthe et al., 2004) and a
well ordered fold for the RPF domain. The only difference observed
is located within a short sequence insertion that is present in the RpfB
RPF domain compared with the other four M. tuberculosis RPF
proteins (Figs. 1c and 2b). In RpfC two residues display an elongated
conformation (42GVGN45), very similar to RpfE (137GSGS140), to
connect -helices 2 and 3, while a 310-helix (
321GLRYAPR327) is
present in RpfB. This small change within the secondary-structure
composition does not change the relative orientation of -helices 2
and 3 within the RPF fold (Fig. 1c). The variation in surface charge
between RpfB and RpfE has previously been noted (Mavrici et al.,
2014). RpfC has two lysines, Lys26 and Lys33, on one side of the
sugar-binding cleft, which are tyrosines in RpfA, RpfB and RpfD or a
leucine in RpfE and serine or threonine in RpfA, RpfD and RpfE or
an aspartate in RpfB (Fig. 2b), respectively. This leads to a different
charge distribution around the ligand-binding pocket, which may
have a role in specificity (Fig. 2c). Mavrici et al. (2014) suggested that
structural communications
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Figure 2
Sequence and charge variation and conservation. (a) Sequence identity between the five M. tuberculosis RPF domains calculated using MUSCLE (Edgar, 2004). (b)
Alignment of the RPF domains of RpfA, RpfB, RpfC, RpfD and RpfE. The number ranges in the names correspond to the UniProt entry. The numbering along the sequence
is that of the mature RpfC after signal sequence cleavage and also of the PDB entry. (c) Electrostatic surfaces of RpfB, RpfC and RpfE showing the variation in electrostatics
around the saccharide-binding cleft. The triNAG of RpfB from the structure superposition is shown in all three images and the images are from the same viewpoint.
Arg126 may play a role in binding the peptide part of the pepti-
doglycan, conferring specificity on RpfE.
4. Conclusion
The RpfC structure catalytic domain displays a high degree of
structural conservation with the other members of the mycobacterial
resuscitation-promoting factor family. Based on the structure that we
have solved, we propose that the five RPFs from M. tuberculosis have
similar substrates, although variation in charge around the active site
may give rise to small variations in the specificity for different
peptidoglycan modifications. The high degree of conservation of the
RPF domain explains why the protein is functionally redundant, but
most importantly shows that the auxiliary domain composition is
mainly responsible for the functional variability.
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